HKSE - Delayed Quote • HKD
Simcere Pharmaceutical Group Limited (2096.HK)
At close: April 26 at 4:08 PM GMT+8
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 8 | 8 |
| Avg. Estimate | 0 | 0 | 0.4 | 0.52 |
| Low Estimate | 0 | 0 | 0.39 | 0.49 |
| High Estimate | 0 | 0 | 0.43 | 0.55 |
| Year Ago EPS | -- | -- | 0.3 | 0.4 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 8 | -- | 8 | 8 |
| Avg. Estimate | 8.29B | -- | 8.29B | 9.67B |
| Low Estimate | 8.02B | -- | 8.02B | 9.13B |
| High Estimate | 8.59B | -- | 8.59B | 10.35B |
| Year Ago Sales | 7.29B | -- | 7.29B | 8.29B |
| Sales Growth (year/est) | 13.70% | -- | 13.70% | 16.50% |
Earnings History
| CURRENCY IN USD | ||||
|---|---|---|---|---|
| EPS Est. | -- | -- | -- | -- |
| EPS Actual | -- | -- | -- | -- |
| Difference | -- | -- | -- | -- |
| Surprise % | -- | -- | -- | -- |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0.4 | 0.52 |
| 7 Days Ago | 0 | 0 | 0.4 | 0.52 |
| 30 Days Ago | 0 | 0 | 0.4 | 0.52 |
| 60 Days Ago | 0 | 0 | 0.45 | 0.58 |
| 90 Days Ago | 0 | 0 | 0.52 | 0.67 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | 2096.HK | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 6.50% |
| Next Qtr. | -- | -- | -- | 12.00% |
| Current Year | 33.30% | -- | -- | 5.30% |
| Next Year | 30.00% | -- | -- | 13.10% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
No Fair Value available for this ticker